X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (258) 258
Publication (19) 19
Book Review (5) 5
Conference Proceeding (4) 4
Book / eBook (3) 3
Book Chapter (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (95) 95
oncology (74) 74
index medicus (59) 59
female (41) 41
male (41) 41
cancer (38) 38
lung neoplasms - drug therapy (33) 33
aged (30) 30
middle aged (30) 30
carcinoma, non-small-cell lung - drug therapy (29) 29
chemotherapy (29) 29
antineoplastic agents - therapeutic use (28) 28
care and treatment (28) 28
lung cancer (27) 27
adult (26) 26
lung cancer, non-small cell (24) 24
treatment outcome (22) 22
immunotherapy (21) 21
antineoplastic combined chemotherapy protocols - therapeutic use (20) 20
research (19) 19
health aspects (18) 18
lung neoplasms - pathology (18) 18
animals (17) 17
carcinoma, non-small-cell lung - pathology (16) 16
non-small cell lung cancer (16) 16
bevacizumab (15) 15
prognosis (15) 15
respiratory system (15) 15
clinical trials (14) 14
medicine, research & experimental (14) 14
nsclc (14) 14
combined modality therapy (13) 13
lung neoplasms - therapy (13) 13
aged, 80 and over (12) 12
clinical trials as topic (12) 12
disease-free survival (12) 12
lung neoplasms - genetics (12) 12
medicine, general & internal (12) 12
survival (12) 12
tumors (12) 12
1st-line treatment (11) 11
antineoplastic agents - pharmacology (11) 11
carcinoma, non-small-cell lung - therapy (11) 11
cetuximab (11) 11
erlotinib (11) 11
gefitinib (11) 11
antibodies, monoclonal - therapeutic use (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
carcinoma, non-small-cell lung - genetics (10) 10
docetaxel (10) 10
drug therapy (10) 10
expression (10) 10
hematology, oncology and palliative medicine (10) 10
medicine & public health (10) 10
non-small-cell lung cancer (10) 10
open-label (10) 10
phase-ii trial (10) 10
solid tumors (10) 10
targeted therapy (10) 10
antimitotic agents (9) 9
antineoplastic agents (9) 9
development and progression (9) 9
epidermal growth factor (9) 9
head and neck cancer (9) 9
metastasis (9) 9
pharmacology & pharmacy (9) 9
physiological aspects (9) 9
protein kinase inhibitors - therapeutic use (9) 9
randomized-trial (9) 9
review (9) 9
squamous-cell carcinoma (9) 9
taxoids - administration & dosage (9) 9
trial (9) 9
tyrosine kinase inhibitor (9) 9
antineoplastic agents - adverse effects (8) 8
cancer vaccines - therapeutic use (8) 8
carcinoma, non-small-cell lung - immunology (8) 8
cell lung-cancer (8) 8
cisplatin (8) 8
diagnosis (8) 8
dosage and administration (8) 8
health care sciences & services (8) 8
lung neoplasms - immunology (8) 8
lung neoplasms - metabolism (8) 8
medicine (8) 8
phase-ii (8) 8
phase-iii (8) 8
radiotherapy (8) 8
bortezomib (7) 7
cancer vaccines (7) 7
carboplatin (7) 7
carcinoma, non-small-cell lung - metabolism (7) 7
combination (7) 7
genetic aspects (7) 7
head and neck neoplasms - drug therapy (7) 7
health policy & services (7) 7
lung-cancer (7) 7
medical ethics (7) 7
medical laboratory technology (7) 7
medicine, legal (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, ISBN 9780702028892, xxi, 256
Book
Laboratory Investigation, ISSN 0023-6837, 11/2017, Volume 97, Issue 11, pp. 1268 - 1270
Neurotrophic tyrosine kinase genes encode for the Trk-family proteins TrkA, TrkB, and TrkC, which have an important role in the development of the nervous... 
MEDICINE, RESEARCH & EXPERIMENTAL | ADVANCED SOLID TUMORS | ENTRECTINIB | ORAL PAN-TRK | RELEVANT MOLECULAR ALTERATIONS | PATHOLOGY | ALK INHIBITOR | ROS1 | EXPRESSION | Lung Neoplasms - drug therapy | Oncogene Proteins, Fusion - metabolism | Membrane Glycoproteins - metabolism | Humans | Lung Neoplasms - metabolism | Receptor, trkA - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Receptor, trkB - genetics | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Antineoplastic Agents - adverse effects | Neoplasms, Squamous Cell - drug therapy | Receptor, trkB - antagonists & inhibitors | Lung Neoplasms - genetics | Molecular Targeted Therapy - adverse effects | Receptor, trkC - antagonists & inhibitors | Membrane Glycoproteins - genetics | Animals | Neoplasms, Squamous Cell - genetics | Receptor Protein-Tyrosine Kinases - genetics | Receptor, trkA - metabolism | Oncogene Proteins, Fusion - genetics | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Receptor, trkB - metabolism | Receptor, trkC - metabolism | Neoplasms, Squamous Cell - metabolism | Toxicity | Lung cancer | Clinical trials | Fluorescence | Nervous system | Kinases | Proteins | Fluorescence in situ hybridization | TrkA protein | TrkA receptors | Protein-tyrosine kinase | Tyrosine | Medical research | Squamous cell carcinoma | Invasiveness | Feasibility studies | Lung carcinoma | Patients | Brain-derived neurotrophic factor | Inhibitors | TrkB receptors | Solid tumors | Tumors | Cancer | Plastic foam | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 8, pp. 731 - 739
Journal Article
Journal Article
Oncology, ISSN 0030-2414, 04/2019, Volume 96, Issue 4, pp. 207 - 216
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2007, Volume 357, Issue 17, pp. 1705 - 1715
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 11, pp. 1415 - 1421
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2/2013, Volume 71, Issue 2, pp. 523 - 530
Journal Article
Lung Cancer Management, ISSN 1758-1966, 04/2016, Volume 5, Issue 1, pp. 1 - 4
Journal Article
Targeted Oncology, ISSN 1776-2596, 10/2018, Volume 13, Issue 5, pp. 541 - 544
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11523-018-0593-y 
CELL LUNG-CANCER | MULTIPLE-MYELOMA | SURVIVAL | METASTATIC MELANOMA | SOLID TUMORS | ONCOLOGY | MICROSATELLITE INSTABILITY | LONG-TERM SAFETY | PAPILLARY THYROID-CANCER | BRAF V600E MUTATION | COLORECTAL-CARCINOMA | Antimitotic agents | Care and treatment | Drug therapy | Antineoplastic agents | Health aspects | Cancer | Targeted cancer therapy
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 9, pp. 1140 - 1145
Journal Article
TRANSLATIONAL LUNG CANCER RESEARCH, ISSN 2218-6751, 12/2018, Volume 7, Issue Suppl 4, pp. S362 - S363
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e18113 - e18113
Journal Article
Journal of Thoracic Disease, ISSN 2072-1439, 04/2018, Volume 10, Issue S9, pp. S1076 - S1080
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e13582 - e13582
Journal Article
Journal Article